Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $9.32 | Prev. Close $9.33 | Circuit Range N/A |
Day Range $9.32 - $9.77 | Year Range $5.01 - $10.64 | Volume 44,490 |
Average Traded $9.61 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Feb-26 | $9.06 | $9.22 | -0.11% |
19-Feb-26 | $8.64 | $9.23 | +6.28% |
18-Feb-26 | $8.62 | $8.69 | +0.17% |
17-Feb-26 | $8.57 | $8.67 | -0.29% |
13-Feb-26 | $8.55 | $8.70 | +3.27% |
12-Feb-26 | $8.94 | $8.42 | -6.13% |
11-Feb-26 | $8.88 | $8.97 | +2.40% |